Promising Psoriasis Pipeline Therapies such as Hypericin, EDP1815, Cetaphil, AX-158, HAT1 topical solution, Calcipotriol, ARQ ...

Calcipotriol plus 5-FU immunotherapy activates Th2 immunity, releasing IL-24 cytokines to suppress skin cancer development in patients with actinic keratosis. The combination therapy significantly ...

Calcipotriol-plus–5-FU therapy activates immune pathways, offering long-lasting protection against squamous cell carcinoma by targeting precancerous lesions.

Dovobet ® (calcipotriol 50 mcg/gm and betamethasone diproprionate 0.5 mcg/g in ointment formulation) may be used concurrently and effectively with UVB/UVA phototherapy.

Clinical trial results detail how topical calcipotriol plus 5-fluorouracil (5-FU) leverages the adaptive immune system to eliminate precancerous lesions and prevent skin cancer.

A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment.

Psoriasis, affecting 2–3% of the global population, is a chronic inflammatory skin condition without a definitive cure. Current treatments focus on managing symptoms. Recognizing the need for ...

LEO Pharma has announced positive data from the Phase III clinical trial of Enstilar (LEO 90100) in Chinese adult patients with stable plaque psoriasis. An aerosol spray foam, enstilar combines ...

Find patient medical information for Calcipotriene/Betamethasone topical on WebMD including its uses, side effects and safety, interactions, pictures, warnings and ...

Topical corticosteroids with vitamin D analogues, such as calcipotriol and tacalcitol, could potentially enhance therapeutic outcomes for vitiligo in conjunction with NB-UVB phototherapy.